Methods of reducing β-amyloid polypeptides

Details Methods of reducing β-amyloid polypeptides Methods of reducing β-amyloid polypeptides

2007-11-27

2007-11-27

Hoffman, Susan Coe (Department: 1655)

Drug, bio-affecting and body treating compositions

Plant material or plant extract of undetermined constitution...

Reexamination Certificate

active

11241573

ABSTRACT:
The invention features methods of reducing the level of a β-amyloid (Aβ) polypeptide using anCimicifugaextract. The invention also features methods of producing an active fraction from an extract ofCimicifuga. The invention further features a composition containing an active fraction of aCimicifugaextract and an article of manufacture containing such a composition.

REFERENCES:
patent: 4469685 (1984-09-01), Kojima et al.
patent: 4666829 (1987-05-01), Glenner et al.
patent: 5538845 (1996-07-01), Knops et al.
patent: 5552426 (1996-09-01), Lunn et al.
patent: 5604102 (1997-02-01), McConlogue et al.
patent: 5703129 (1997-12-01), Felsenstein et al.
patent: 5766846 (1998-06-01), Schlossmacher et al.
patent: 5916565 (1999-06-01), Rose et al.
patent: 6096782 (2000-08-01), Audia et al.
patent: 6191166 (2001-02-01), Audia et al.
patent: 6211235 (2001-04-01), Wu et al.
patent: 59020298 (1984-02-01), None
patent: 09-030977 (1997-04-01), None
patent: 9300059 (1993-01-01), None
Mattson (Nature (2004) vol. 430, pp. 631-639).
NIH Publication No. 05-5503; Can Alzheimer's Disease be Prevented? (2005).
Asami-Okada et al., “Long Amyloid β-Protein Secreted from Wild-Type Human Neuroblastoma IMR-32 Cells,”Biochem, 1995, 34:10272-10278.
Brinker, “Variations in Effective Botanical Products—The Case for Diversity of Forms for Herbal Preparations as Supported by Scientific Studies,”HerbalGram, 1999, 46:36-50.
Buckley, “Separation Techniques,” School of Education and Humanities, North East Wales Institute of Higher Education at http://www.newi.ac.uk/buckleyc/separ.htm accessed Feb. 19, 2001.
Buxbaum et al., “Processing of Alzheimer β/A4 amyloid precursor protein: Modulation by agents that regulate protein phosphorylation,”Proc. Natl. Acad. Sci. USA, 1990, 87:6003-6006.
Buxbaum et al., “Protein phosphorylation inhibits production of Alzheimer amyloid β/A4 peptide,”Proc. Natl. Acad. Sci. USA, 1993, 90:9195-9198.
Chevallier et al., “Cathepsin D displays in vitro β-secretase-like specificity,”Brain Res., 1997, 750:11-19.
Dovey et al., “Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain,”J. Neurochem., 2001, 76:173-181.
Eckman et al., “Degradation of the Alzheimer's Amyloid β Peptide by endothelin-converting Enzyme,”J. Biol. Chem., 2001, 276(27):24540-24548.
Fassbender et al., “Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40in vitroandin vivo,” Proc. Natl. Acad. Sci. USA, 2001, 98(10):5856-5861.
Frears et al., “The role of cholesterol in the biosynthesis of β-amyloid,”NeuroReport, 1999, 10(8):1699-1705.
Gandy, “Neurohormonal Signaling Pathways and the Regulation of Alzheimer β-Amyloid Precursor Metabolism,”Trends Endocrinol. Metab., 1999, 10(7):273-279.
Geriatric Nutritional Review—“Black Cohosh,” AgeNet Eldercare Network at http://www.agenet.com/herbal—supplements/blackcohosh.html, accessed Feb. 7, 2001.
Glenbrook Farms, “Herb Facts and Tips, Black Cohosh,” at http://www.glenbrookfarm.com/herbs/blackcoh.htm, accessed Feb. 7, 2001.
Gouras et al., “Testosterone reduces neuronal secretion of Alzheimer's β-amyloid peptides,”Proc. Natl. Acad. Sci. USA, 2000, 97(3):1202-1205.
Haass and Selkoe, “Cellular Processing of β-Amyloid Precursor Protein and the Genesis of Amyloid β-Peptide,”Cell, 1993, 75:1039-1042.
Haass et al., “Normal Cellular Processing of the β-Amyloid Precursor Protein Results in the Secretion of the Amyloid β Peptide and Related Molecules,”Ann. N.Y. Acad. Sci., 695:109-116.
Haugabook et al., “Reduction of Aβ accumulation in the Tg2576 animal model of Alzheimer's disease after oral administraction of the phosphatidyl-inositol kinase inhibitor wortmannin,”FASEB J., 2001, 15:16-18.
Holcomb et al., “Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutantamyloid precursor protein and presenilin 1transgenes,”Nature Med., 1998, 4:97-100.
Hung et al., “Activiation of Protein Kinase C Inhibits Cellular Production of the Amyloid β-Protein,”J. Biol. Chem., 1993, 268(31):22959-22962.
Iversen et al., “The toxicityin vitroof β-amyloid protein,”Biochem J., 1995, 311:1-16.
Jacobsen et al., “Release of Alzheimer's Disease β Amyloid Peptide is Reduced by Phorbol Treatment,”J. Biol. Chem., 1994, 269(11):8376-8382.
King's American Dispensatory, “Cimicifunga (U.S.P.)-Cimicifuga,” at http://www.ibiblio.org/herbmed/eclectic/kings/cimicifuga.html, accessed Feb. 13, 2001.
Koo, “Phorbol Esters Affect Multiple Steps in β-Amyloid Precursor Protein Trafficking and Amyloid β-Protein Production,”Mol. Med., 1997, 3(3):204-211.
Lahiri et al., “The secretion of amyloid β-peptides is inhibited in the tacrine-treated human neuroblastoma cells,”Mol. Brain Res., 1998, 62:131-140.
Lahiri et al., “Cholinesterase inhibitors, β-amyloid precursor protein and amyloid β-peptides in Alzheimer's disease,”Acta Neurol. Scand., 2000, Suppl. 176:60-67.
Lieberman, “Evidence-Based Natural Medicine—A Review of the Effectiveness ofCimicifuga racemosa(Black Cohosh) for the Symptoms of Menopause,”J. Women's Health, 1998, 7(5):525-529.
Lim et al., “Ibuprofen Suppresses Plaque Pathology and Inflammation in a Mouse Model for Alzheimer's Disease,”J. Neurosci., 2000, 20(15):5709-5714.
Masters et al., “Amyloid plaque core protein in Alzheimer disease and Down syndrome,”Proc. Natl. Acad. Sci. USA, 1985, 82:4245-4249.
Murray, “Indigestion, antacids, achlorydria and H. pylori,”Am. J. Nat. Med., 1997, 4:11-14, 16-17.
Nitsch et al., “The Selective Muscarinic M1 Agonist AF102B Decreases Levels of Total Aβ in Cerebrospinal Fluid of Patients with Alzheimer's Disease,”Ann. Neurol., 2000, 48:913-918.
Ohyagi et al., “Selective increase in cellular Aβ42 is related to apoptosis but not necrosis,”NeuroReport., 2000, 11:167-171.
Pagansonline.com, Chemical and Pharmaceutical Bulletin at http://www.pagansonline.com/pagansonline/cimicifuga.htm, accessed Feb. 13, 2001.
Petanceska and Gandy, “The Phosphatidylinositol 3-Kinase Inhibitor Wortmannin Alters the Metabolism of the Alzheimer's Amyloid Precursor Protein,”J. Neurochem., 1999, 73:2316-2320.
Pharmaceutical Information Network, “Black Cohosh,” at http://www.pharminfo.com/cam/BlackCohoshch.html, accessed Feb. 7, 2001.
Querfurth and Selkoe, “Calcium Ionophore Increases Amyloid β Peptide Production by Cultured Cells,”Biochem., 1994, 33(15):4550-4561.
Querfurth et al., “Caffeine Stimulates Amyloid β-Peptide Release from β-Amyloid Precursor Protein-Transfected HEK293 Cells,”J. Neurochem., 1997, 69:1580-1591.
Racchi and Govoni, “Rationalizing a pharmacological intervention on the amyloid precursor protein metabolism,”Trends Pharmacol. Sci., 1999, 20:418-423.
Sambamurti et al., “Glycosylphosphatidylinositol-anchored Proteins Play an Important Role in the Biogenesis of the Alzheimer's Amyloid β-Protein,”J. Biol. Chem., 1999, 274(38):26810-26814.
Savage et al., “Turnover of Amyloid β-Protein in Mouse Brain and Acute Reduction of Its Level by Phorbol Ester,”J. Neurosci., 1998, 18(5):1743-1752.
Shoji et al., “Production of the Alzheimer Amyloid βProtein by Normal Proteolytic Processing,”Science, 1992, 258:126-129.
Suzuki et al., “An Increased Percentage of Long Amyloid β Protein Secreted by Familial Amyloid β Protein Precursor (βAPP717) Mutants,”Science, 1994, 264:1336-1340.
Viable Herbal Solutions, “Black Cohosh,” at http://www.viab

Affiliated with

Also associated with

Rating

Methods of reducing β-amyloid polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of reducing β-amyloid polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of reducing β-amyloid polypeptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3886885